A Study to Assess the Safety, Efficacy, and Pharmacokinetics of Multiple Doses of ION224

NCT04932512 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

160

Enrollment

INDUSTRY

Sponsor class

Conditions

Steatohepatitis, Nonalcoholic

Interventions

DRUG: ION224
OTHER: Placebo

Sponsor

Ionis Pharmaceuticals, Inc.